NCT04990791View on ClinicalTrials.gov

WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 26, 2021

Primary Completion Date

August 31, 2023

Study Completion Date

December 1, 2023

Conditions
Coronary Syndrome
Interventions
DRUG

Aspirin 75mg

Aspirin 75mg OD for 14 days

DRUG

Aspirin 20mg

Aspirin 20mg BD for 14 days

DRUG

Rivaroxaban 2.5 mg

Rivaroxaban 2.5mg BD

Trial Locations (1)

S5 7AU

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

All Listed Sponsors
lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT04990791 - WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes? | Biotech Hunter | Biotech Hunter